Rodenticides Market Projected to Garner Significant Revenues by 2027

The global Rodenticides Market is predicted to experience a 5.8% compound annual growth rate, leading to a revenue surpassing USD 7.1 billion by 2027. This thriving industry, valued at USD 5.4 billion in 2022, is on a path of substantial growth.

The rising concern for environmental pollution and public health hazards posed by vector-borne diseases is fueling the global demand for rodent control services. The growing population, coupled with the overexploitation and degradation of limited resources, is contributing to the degradation of the ecosystem, leading to global warming and temperature rise. These factors, in turn, are indirectly strengthening pests' ability to survive in different seasons, as evidenced by the migration of tropical pests away from the equatorial region due to global warming.

Drivers: Displacement of rodents due to urbanization

Urbanization is one of the key factors encouraging land use, particularly in developing countries, where 90% of the people are expected to be residents of urban areas. Moreover, urbanization is expected to impact public health due to the shift of rural pathogens adapting to the urban environment and increasing their number.

According to an article by Rentokil, it has been observed that the construction of new buildings is increasingly displacing the rat population across regions. As per the report by Building and Construction Authority (BCA), the need for construction in the country is increasing. Some construction activities in rural areas disturb the nesting area of rodents, such as rats, and thus encourage them to relocate to another urbanized location.

According to a recent article posted in Frontiers, Norway, black rats are considered the urban rats that inhabit cities worldwide. They adapt to environmental changes caused by humans and thus survive easily. Hence, the increase in the levels of urbanization creates the need for rodent control, majorly in the urban areas of developing regions.

What is the current size of the global rodenticides market?

Rising Demand for Second-Generation Anticoagulants due to their Longer Half-Life, Which Implies Longer Tissue Persistence, and Enhanced Efficacy Against Rodents

With the increase in exposure to first-generation anticoagulants, rodents have developed resistance to them; hence, second-generation anticoagulants were developed. Second-generation anticoagulants, also called single-dose anticoagulants, can be lethal in a single dose. They are more toxic than first-generation anticoagulants due to their superior affinity for vitamin K-epoxide reductase, which disrupts the functioning of the blood clotting agents in rodents. The popular rodenticides in this category are brodifacoum, bromadiolone, difethialone, difenacoum, and flocoumafen.

Second-generation anticoagulants are not excreted easily, persisting in bodily organs such as the liver. Some of these are particularly toxic to birds and mammals. For instance, brodifacoum and difethialone pose potential risks to avian predators and scavengers that feed on target or non-target animals poisoned with bait. Oral toxicity is high in nearly all rodenticides. Most of these are not allowed to be marketed to non-licensed applicators for residential use. These products are sold directly to pest control professionals or agricultural supply stores.

Key players operating in this market include BASF SE (Germany), Bayer AG (Germany), Syngenta AG (Switzerland), UPL Limited (India), Rollins, Inc. (US), Liphatech, Inc. (US), JT Eaton & Co., Inc. (US), Pelgar (UK), Bell Laboratories Inc. (US), and Abell Pest Control (Canada).